(Q34371989)

1 August 2017

title

Safety of tenofovir during pregnancy for the mother and fetus: a systematic review (English)

1 reference

Jennifer Legardy-Williams

1 August 2017

1 reference

1 reference

4

object named as

Jennifer Legardy-Williams

0 references

Athena P. Kourtis

object named as

Athena P Kourtis

2

0 references

Marc Bulterys

5

object named as

Marc Bulterys

1 reference

1 August 2017

3

Sascha Ellington

1 reference

1 August 2017

Liming Wang

1

1 reference

1 August 2017

Jennifer Legardy-Williams

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

17 September 2013

1 reference

Clinical Infectious Diseases

1 August 2017

published in

1 reference

1 August 2017

volume

57

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

1773-1781

1 reference

Prevention of mother-to-child transmission of HIV: antiretroviral strategies

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Preexposure prophylaxis for HIV infection among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Adverse effects of tenofovir use in HIV-infected pregnant women and their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Serial studies of renal function during pregnancy and the puerperium in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Mitochondrial toxicity of antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

HIV-HBV coinfection--a global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Candidates for therapy: HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT601

21 January 2018

Identifiers

DOI

10.1093/CID/CIT601

1 reference

1 August 2017

1 reference